二氧化硅纳米颗粒的临床转化
Clinical translation of silica nanoparticles.
作者信息
Janjua Taskeen Iqbal, Cao Yuxue, Yu Chengzhong, Popat Amirali
机构信息
School of Pharmacy, The University of Queensland, Brisbane, Queensland Australia.
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland Australia.
出版信息
Nat Rev Mater. 2021;6(12):1072-1074. doi: 10.1038/s41578-021-00385-x. Epub 2021 Oct 7.
PMID:34642607
Abstract
Silica nanoparticles have entered clinical trials for a variety of biomedical applications, including oral drug delivery, diagnostics, plasmonic resonance and photothermal ablation therapy. Preliminary results indicate the safety, efficacy and viability of silica nanoparticles under these clinical scenarios.
摘要
二氧化硅纳米颗粒已进入多种生物医学应用的临床试验，包括口服药物递送、诊断、等离子体共振和光热消融治疗。初步结果表明了二氧化硅纳米颗粒在这些临床情况下的安全性、有效性和可行性。
Zotero 插件